Aristotle Capital Management, LLC Baxter International Inc Transaction History

Aristotle Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$63.43 - $75.41 $116,774 - $138,829	-1,841 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$62.56 - $72.26 $38.7 Million - $44.7 Million	-618,609 Reduced 99.7%	1,841 $120,000
Q4 2017 Feb 14, 2018	SELL	$61.45 - $66.05 $390 Million - $419 Million	-6,340,769 Reduced 91.09%	620,450 $40.1 Million
Q3 2017 Nov 14, 2017	BUY	$59.5 - $64.61 $6.84 Million - $7.42 Million	114,912 Added 1.68%	6,961,219 $437 Million
Q2 2017 Nov 16, 2017	BUY	N/A	116,535 Added 1.73%	6,846,307 $414 Million
Q1 2017 Nov 16, 2017	SELL	N/A	-48,785 Reduced 0.72%	6,729,772 $349 Million
Q4 2016 Nov 16, 2017	BUY	N/A	166,033 Added 2.51%	6,778,557 $301 Million
Q3 2016 Nov 16, 2017	SELL	N/A	-105,153 Reduced 1.57%	6,612,524 $315 Million
Q2 2016 Nov 16, 2017	BUY	N/A	137,113 Added 2.08%	6,717,677 $304 Million
Q1 2016 Nov 17, 2017	BUY	N/A	38,858 Added 0.59%	6,580,564 $270 Million
Q4 2015 Nov 16, 2017	BUY	N/A	1,364,103 Added 26.35%	6,541,706 $250 Million
Q3 2015 Nov 16, 2017	BUY	N/A	5,177,603	5,177,603 $170 Million

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Aristotle Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aristotle Capital Management, LLC with notifications on news.